Evaluating the effects of sophrology on cigarette craving during withdrawal
Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal
This study is testing if sophrology can help people who are quitting smoking feel less craving for cigarettes during withdrawal.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 2 sites (Créteil and 1 other locations) |
| Trial ID | NCT04700306 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to assess the effectiveness of sophrology in reducing the intensity of cravings experienced by individuals undergoing cigarette withdrawal. Participants will be monitored for various factors related to smoking cessation, including the number of cigarettes smoked, anxiety levels, dependence, motivation, confidence, fatigue, irritability, and sleep quality. The findings from this study could provide foundational insights for larger-scale research in the future.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 who smoke at least 35 cigarettes per week and are seeking help for tobacco addiction.
Not a fit: Patients with co-addictions, pregnant women, or those with psychosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a new therapeutic approach to help individuals manage cravings and improve their chances of quitting smoking.
How similar studies have performed: While this approach is relatively novel, previous studies on mindfulness and similar interventions have shown promise in managing cravings in addiction.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * First outpatient consultation in tobacco addiction department * Consumption greater than or equal to 35 cigarettes per week * Minimum age: 18 years old / Maximum age: 75 years old * Absence of co-addiction of alcohol, other products and behavioural addictions (except if withdrawal for more than 1 year) * Commitment by the patient not to practice hypnosis or mindfulness while participating in the study * Mastering reading and writing skills * Acceptance to participate in the protocol * Affiliated to a social security system Exclusion Criteria: * Patient-reported psychosis * Pregnant women * Participation in other intervention research * Patient under guardianship or curatorship * Refusal to participate in the study
Where this trial is running
Créteil and 1 other locations
- CHI Créteil Equipe de liaison et de soins en addictologie (ELSA) — Créteil, France (Recruiting)
- CHU Henri Mondor Service d'addictologie — Créteil, France (Recruiting)
Study contacts
- Principal investigator: Sylvie Ané — Centre Hospitalier Intercommunal Créteil
- Study coordinator: Sylvie Ané
- Email: sylvie.ane@chicreteil.fr
- Phone: 0145175035
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.